302 related articles for article (PubMed ID: 8258617)
1. Duration of venom immunotherapy: relationship to the severity of symptoms of initial insect sting anaphylaxis.
Reisman RE
J Allergy Clin Immunol; 1993 Dec; 92(6):831-6. PubMed ID: 8258617
[TBL] [Abstract][Full Text] [Related]
2. Further observations of stopping venom immunotherapy: comparison of patients stopped because of a fall in serum venom-specific IgE to insignificant levels with patients stopped prematurely by self-choice.
Reisman RE; Lantner R
J Allergy Clin Immunol; 1989 Jun; 83(6):1049-54. PubMed ID: 2732405
[TBL] [Abstract][Full Text] [Related]
3. Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions.
Reisman RE
J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):335-9. PubMed ID: 1345753
[TBL] [Abstract][Full Text] [Related]
4. Hymenoptera venom immunotherapy and field stings.
Lang R; Hawranek T
J Investig Allergol Clin Immunol; 2006; 16(4):224-31. PubMed ID: 16889279
[TBL] [Abstract][Full Text] [Related]
5. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice.
Bonifazi F; Jutel M; Biló BM; Birnbaum J; Muller U;
Allergy; 2005 Dec; 60(12):1459-70. PubMed ID: 16266376
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Follow-Up of Children after Venom Immunotherapy: Low Adherence to Anaphylaxis Guidelines.
Fiedler C; Miehe U; Treudler R; Kiess W; Prenzel F
Int Arch Allergy Immunol; 2017; 172(3):167-172. PubMed ID: 28380475
[TBL] [Abstract][Full Text] [Related]
7. Survey of patients after discontinuing venom immunotherapy.
Golden DB; Kagey-Sobotka A; Lichtenstein LM
J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):385-90. PubMed ID: 10669863
[TBL] [Abstract][Full Text] [Related]
8. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
Stritzke AI; Eng PA
Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
[TBL] [Abstract][Full Text] [Related]
10. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
Bonadonna P; Zanotti R; Pagani M; Bonifacio M; Scaffidi L; Olivieri E; Franchini M; Reccardini F; Costantino MT; Roncallo C; Mauro M; Boni E; Rizzini FL; Bilò MB; Marcarelli AR; Passalacqua G
J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge.
van Halteren HK; van der Linden PW; Burgers JA; Bartelink AK
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):767-70. PubMed ID: 9438484
[TBL] [Abstract][Full Text] [Related]
12. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
Spoerl D; Bircher AJ; Scherer K
J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
[TBL] [Abstract][Full Text] [Related]
13. The value of immunotherapy with venom in children with allergy to insect stings.
Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
[TBL] [Abstract][Full Text] [Related]
14. Natural history of Hymenoptera venom allergy in children not treated with immunotherapy.
Lange J; Cichocka-Jarosz E; Marczak H; Krauze A; Tarczoń I; Świebocka E; Lis G; Brzyski P; Nowak-Węgrzyn A
Ann Allergy Asthma Immunol; 2016 Mar; 116(3):225-9. PubMed ID: 26945496
[TBL] [Abstract][Full Text] [Related]
15. Late-onset allergic reactions, including serum sickness, after insect stings.
Reisman RE; Livingston A
J Allergy Clin Immunol; 1989 Sep; 84(3):331-7. PubMed ID: 2778239
[TBL] [Abstract][Full Text] [Related]
16. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.
Ruëff F; Vos B; Oude Elberink J; Bender A; Chatelain R; Dugas-Breit S; Horny HP; Küchenhoff H; Linhardt A; Mastnik S; Sotlar K; Stretz E; Vollrath R; Przybilla B; Flaig M
Clin Exp Allergy; 2014; 44(5):736-46. PubMed ID: 24447114
[TBL] [Abstract][Full Text] [Related]
17. When can immunotherapy for insect sting allergy be stopped?
Müller UR; Ring J
J Allergy Clin Immunol Pract; 2015; 3(3):324-8; quiz 329-30. PubMed ID: 25956311
[TBL] [Abstract][Full Text] [Related]
18. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
Baenkler HW; Meusser-Storm S; Eger G
Allergol Immunopathol (Madr); 2005; 33(1):7-14. PubMed ID: 15777517
[TBL] [Abstract][Full Text] [Related]
19. Bee-venom allergy in children: long-term predictive value of standardized challenge tests.
Schuetze GE; Forster J; Hauk PJ; Friedl K; Kuehr J
Pediatr Allergy Immunol; 2002 Feb; 13(1):18-23. PubMed ID: 12000494
[TBL] [Abstract][Full Text] [Related]
20. Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity.
Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Seitz MJ; Aberer W; Bodzenta-Lukaszyk A; Bonifazi F; Campi P; Darsow U; Haeberli G; Hawranek T; Küchenhoff H; Lang R; Quercia O; Reider N; Schmid-Grendelmeier P; Severino M; Sturm GJ; Treudler R; Wüthrich B
PLoS One; 2013; 8(5):e63233. PubMed ID: 23700415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
